In contrast, the MetS/E + EX group, which includes the SIRT1 inhibitor EX527, showed insignificant change in these parameters compared to the MetS group, except for fasting serum insulin and OGTT AUC (p < 0.01 and 0.05). Here, INS is linked to metabolic syndrome.